Apollo Diagnostics launches 1500th pathology centre, at Kothapet

The newly launched spacious pathology centre serves a comprehensive menu of more than 3,000 tests

Apollo Diagnostics announced the launch of their fifteen hundredth pathology centre, at Mohan Nagar, Kothapet, Hyderabad. Vishwajit Reddy Konda, Chief Growth Officer, Apollo Diagnostics, formally inaugurated this centre. The newly launched spacious pathology centre serves a comprehensive menu of more than 3,000 tests, performed under the supervision of highly experienced pathologists.

Apollo Diagnostics has a Global Reference Laboratory in Hyderabad, with 1500 patient care centres and over 120 labs spread across India. It is NABL certified (National Accreditation Board for Testing and Calibration Laboratories) and CAP-accredited (College of American Pathologists). It is also approved by ICMR for COVID-19 RT PCR testing and administers the same following ICMR and state government regulations.

On this occasion, Konda said, “Currently, we are operating 120 Labs pan India, and this 1500th centre is a milestone in our journey. We are shifting our focus to make available speciality high-end testing at the patient’s doorstep, building a long-term relationship with them, tracking their parameters and guiding them to a healthy lifestyle. We are moving further into the deeper pockets of the cities to accomplish this. Accurate diagnosis plays an important role in the timely detection of disease, which enables doctors to diagnose health disorders accurately and provide the right treatment protocols to a patient, for improved quality of life. The newly launched centre is a one-stop destination for all pathology tests that provides accurate reports and quick testing, with the most efficient service delivery for all. Patients can avail of home collection services by booking the tests online, and can also download their reports at their convenience.”

“Our focus is on clinical excellence, and we want to bring a revolutionary transformation to our healthcare system, by providing state-of-the-art technology infrastructure and advanced diagnostic tests. We are planning to set up 1,000 more patient care centres across interior regions in India, for accessibility of pathological investigation,” said Konda.

The dedicated and skilled team at Apollo Diagnostics, with vaccinated phlebotomists and pathologists, is committed to providing correct diagnoses for the safety of each person. It aims to cover as many people as possible, for them to have access to high-quality diagnostics and accurate reports, which can improve their overall quality of life.

Chandra Sekhar C, CEO, Apollo Health and Lifestyle, said, “The need for world-class diagnostic services is propelling Apollo Diagnostics to foray into newer locations. The fifteen hundredth pathology centre at Mohan Nagar, Kothapet is a major milestone and gives us the impetus to reach out to areas eagerly awaiting an Apollo Diagnostics centre.”

Sushant Kinra, COO, Apollo Diagnostics said, “Our vision is to have 3000 to 4000 pathology centres across the country. We are keen to focus on the well-being of our population and in pursuit of that, we want to make quality healthcare accessible to everyone. Our thrust is on preventive care, we have packages which asses your wellness and in case of early signs of disease, preventive care can nip it in bud. Therefore, we are opening centres across Hyderabad and India at the rate of three to four centres per day, that’s the scale at which we are expanding to make quality healthcare accessible to all.”

Devendra Singh Rajput, Vice President, Apollo Diagnostics said, “We will be reaching 5000 pathology centres and 300 labs in two years, that’s the vision and roadmap Apollo Diagnostics has. We are also offering digital solutions to the customers, our reports will be shared via email and WhatsApp and have a digital App 24/7, which enables patients to book a home service from the comfort of their home. The thrust of our preventive health packages will be on non-communicable diseases like diabetes, cancer and cardiac disorders, which are going to be the main worry factor for India.”




Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Back to top button